Navigation Links
EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
Date:6/18/2008

Experienced Biotech Business Development and Investment Banker Enhances

EntreMed's Senior Management Team

ROCKVILLE, Md., June 18 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the appointment of Mr. Thomas H. Bliss, Jr. as Senior Vice President, Corporate and Business Development. Mr. Bliss has been elected an executive officer by EntreMed's Board of Directors and will report to the Company's President and Chief Executive Officer, Mr. James S. Burns.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Most recently the Executive Director, Licensing at Amgen, Mr. Bliss brings nearly 20 years biotechnology business development and healthcare investment banking experience to EntreMed. In his most recent role at Amgen, Mr. Bliss was responsible for international licensing, licensing operations oversight and the coordination and communication of Amgen's China/India Research Activities Initiative. Previous to that, Mr. Bliss was responsible for directing all Amgen acquisition activity, including the acquisition of Abgenix. Prior to joining Amgen in 2004, Mr. Bliss served as Vice President, BioPharmaceuticals Business Development at Baxter BioScience, where he directed all licensing and acquisition activities.

Mr. Bliss' career in life science business development began in 1994 with Johnson & Johnson where he provided analytical support for all franchises and participated in the creation of billion dollar cardiovascular access and orthopedic businesses. The first
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
2. EntreMed Appoints Senior Vice President of Research and Development
3. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
4. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
5. EntreMed to Present at BIO CEO and Investor Conference
6. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
7. EntreMed Announces 2008 Corporate and Clinical Program Priorities
8. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
9. EntreMed Receives Nasdaq Deficiency Notice
10. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
11. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... 2015 on Friday, May 8 before the market opens. ... and conference call at 8:30 a.m. Eastern Time (5:30 ... be accessed by phone by calling (800) 708-4540 (domestic) ... can be accessed live on the Investors section of ...
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Synedgen ... Nguyen, PhD as Regulatory Affairs Manager. , Dr. Nguyen ... an important juncture for the company as it moves ... drug products over the next two years. Dr. Nguyen ... of all the regulatory key documents that must be ...
(Date:5/4/2015)... 4, 2015   St. Jude Children,s Research ... computer tool for finding genetic alterations that play ... difficult to identify with whole-genome sequencing. The findings ... Methods . The tool is an ... by Regression Tree in Next Generation Sequencing. ...
(Date:5/4/2015)... - The Fight Against Cancer Innovation Trust (FACIT) ... formation of Turnstone Biologics Inc. (Turnstone), a biotechnology ... harness the patient,s own immune system. ... Children,s Hospital of Eastern Ontario ... Institute for Cancer Research (OICR), the Ottawa Hospital ...
Breaking Biology Technology:Synedgen Announces the Appointment of Regulatory Affairs Manager 2Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3
... Regulatory Pathway Would Also Lower Total,Expenditures for Biologics by ... The Congressional Budget,Office (CBO) today released a cost ... follow-on biologics -- or biogenerics -- would save,the federal ... for biologics by $25 billion over the same time ...
... MONTREAL, June 25 /PRNewswire-FirstCall/ - ProMetic Life ... has further confirmed the,efficacy of the prion ... Technologies Inc. ("PRDT"), in the removal of ... containing high,concentrations of specific proteins such as ...
... changing against management - with six million, votes ... to change rules, TORONTO, June 25 /PRNewswire/ - ... will be in court today and will seek a,declaration ... General Meeting,was illegally held and will request that a ...
Cached Biology Technology:CBO: Biogenerics Would Save Federal Government $6.6 Billion Over Ten Years 2ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference 2ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference 3
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... A gene from the measles virus plays a key ... to a team of researchers led by the University of ... Cell Metabolism , confirm a long-held speculation that the childhood ... how the viral gene contributes to the development of its ...
... record to understand the evolutionary and ecological responses ... putting the dead to work. A new ... provides examples of how the fossil record can ... be most vulnerable to environmental changes, and provide ...
... pregnant women carry multiple chemicals, including some banned since ... as non-stick cookware, processed foods and personal care products, ... study marks the first time that the number of ... counted. Analyzing data for 163 ...
Cached Biology News:Measles virus plays role in Paget's disease of bone, Pitt-led team says 2Putting the dead to work 2Putting the dead to work 3UCSF study identifies chemicals in pregnant women 2
... PROTEAN II xi 2-D system runs both gel dimensions ... tube gels can be separated in a single run ... cooling core in much the same manner as the ... the second-dimension slab gels may be cast in the ...
... all the accessories necessary for casting gels ... analysis (SSCP) with the DCode universal mutation ... finger adaptor for use with an external ... cm plates, 2 sets of 0.75 mm ...
...
...
Biology Products: